Evidence map›Paper›PMID 21801572›Full record

ReviewThe British journal of general practice : the journal of the Royal College of General Practitioners2011

Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method.

Anthony J Avery, Grant M Dex, Caroline Mulvaney, Brian Serumaga, Rachel Spencer, Helen E Lester, Stephen M Campbell

Abstract readReview
In one paragraph

Review in The British journal of general practice : the journal of the Royal College of General Practitioners, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Identification of an updated set of prescribing--safety indicators for GPs.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Pooled it
  6. Trial
  7. Trial
  8. Regional research priorities for medication safety and pharmacovigilance in gulf cooperation council countries: a modified Delphi consensus study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Developing the Resident Measure of Safety in Care Homes (RMOS): A Delphi and Think Aloud Study.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anthony J AverySchool of Community Health Sciences, University of Nottingham, Nottingham, UK. tony.avery@nottingham.ac.uk
Grant M Dex
Caroline Mulvaney
Brian Serumaga
Rachel Spencer
Helen E Lester
Stephen M Campbell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the UK, a process of revalidation is being introduced to allow doctors to demonstrate that they meet current professional standards, are up-to-date, and fit to practise. Given the serious risks to patients from hazardous use of medicines it will be appropriate, as part of the revalidation process, to assess the safety of prescribing by GPs.

aimTo identify a set of potential prescribing-safety indicators for the purposes of revalidation of individual GPs in the UK. DESIGN AND

settingThe RAND Appropriateness Method was used to identify, develop, and obtain agreement on the indicators in UK general practice.

methodTwelve GPs from across the UK with a wide variety of characteristics assessed indicators for appropriateness of use in revalidation.

resultsForty-seven safety indicators were considered appropriate for assessing the prescribing safety of individual GPs for the purposes of revalidation (appropriateness was defined as an overall panel median score of ≥ 7 (on a 1-9 scale), with no more than three panel members rating the indicator outside the 3-point distribution around the median]. After removing indicators that were variations on the same theme, a final set of 34 indicators was obtained; these cover hazardous prescribing across a range of therapeutic areas, hazardous drug-drug combinations, prescribing with a history of allergy, and inadequate laboratory-test monitoring.

conclusionThis study identified a set of 34 indicators that were considered, by a panel of 12 GPs, to be appropriate for use in assessing the safety of GP prescribing for the purposes of revalidation. Violation of any of the 34 indicators indicates a potential patient-safety problem.

Indexed as

AccreditationDrug PrescriptionsDrug-Related Side Effects and Adverse ReactionsFamily PracticeFemaleHumansMalePharmaceutical PreparationsPractice Patterns, Physicians'Quality Indicators, Health CareSafety ManagementUnited KingdomPharmaceutical Preparations

Identifiers

PMID21801572
PMCPMC3145537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.